- Home
- WRBY vs VERA Comparison
WRBY vs VERA Comparison
Compare WRBY & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- VERA
- Stock Information
- Founded
- WRBY 2010
- VERA 2016
- Country
- WRBY United States
- VERA United States
- Employees
- WRBY N/A
- VERA N/A
- Industry
- WRBY Ophthalmic Goods
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- VERA Health Care
- Exchange
- WRBY Nasdaq
- VERA Nasdaq
- Market Cap
- WRBY 2.7B
- VERA 2.0B
- IPO Year
- WRBY 2021
- VERA 2021
- Fundamental
- Price
- WRBY $22.19
- VERA $23.82
- Analyst Decision
- WRBY Buy
- VERA Buy
- Analyst Count
- WRBY 16
- VERA 8
- Target Price
- WRBY $23.33
- VERA $64.63
- AVG Volume (30 Days)
- WRBY 1.8M
- VERA 1.4M
- Earning Date
- WRBY 08-07-2025
- VERA 08-07-2025
- Dividend Yield
- WRBY N/A
- VERA N/A
- EPS Growth
- WRBY N/A
- VERA N/A
- EPS
- WRBY N/A
- VERA N/A
- Revenue
- WRBY $795,094,000.00
- VERA N/A
- Revenue This Year
- WRBY $16.13
- VERA N/A
- Revenue Next Year
- WRBY $13.87
- VERA N/A
- P/E Ratio
- WRBY N/A
- VERA N/A
- Revenue Growth
- WRBY 13.94
- VERA N/A
- 52 Week Low
- WRBY $12.46
- VERA $18.53
- 52 Week High
- WRBY $28.68
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- WRBY 57.54
- VERA 52.93
- Support Level
- WRBY $21.13
- VERA $22.57
- Resistance Level
- WRBY $22.72
- VERA $24.58
- Average True Range (ATR)
- WRBY 0.84
- VERA 1.22
- MACD
- WRBY -0.09
- VERA 0.14
- Stochastic Oscillator
- WRBY 71.85
- VERA 69.80
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.